Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03293875 · ClinicalTrials.gov registry record · NA
Adaptation and Implementation of Project Encuentro in the U.S.-Mexico Border
A NA study, sponsored by City University of New York.
- Completed
- Registry status
- NA
- Development phase
- 840
- Enrollment target
NCT03293875: Completed NA study, sponsored by City University of New York.
NCT03293875 is a NA study that has completed, run by City University of New York. The registered enrollment target is 840 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (40% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03293875, a NA study, has completed, sponsored by City University of New York.
- COMPLETED
- Registry status
- NA
- Development phase
- 840 participants
- Enrollment target
Study Summary
The proposed project is a research collaboration between the University of Texas at El Paso, The Alliance for Border Collaboratives in El Paso, Texas and Programa Companeros in Juarez City, Mexico to adapt, implement, and evaluate a multi-level community-based HIV prevention intervention (Project Encuentro). The intervention will target people who inject drugs (PWID) and consists of: 1) A social network HIV testing component, 2) a peer network psychoeducational intervention, and 3) community events. The intervention was developed in an area severely affected by violence and stigma towards people who use drugs (PWUD), El Salvador, which makes it particularly suitable for adaptation to meet the needs of PWUD living in the proposed intervention site, the U.S.-Mexico border. The proposed intervention site also has been severely affected by violence which has curtailed any prior attempts to reduce the risk of HIV acquisition among PWUD. Violence has worsened structural factors which affect HIV risk such as, increasing police persecution, stigma and reducing access to harm reduction resources. The investigators will engage in formative research to understand the context of HIV risk for PWID in the border region post violence and adapt the intervention accordingly. Findings will allow the investigators to tailor intervention components to meet the needs of PWID in the region. Subsequently, the investigators propose to test intervention effectiveness and evaluate implementation barriers and facilitators. To accomplish study aims a mixed qualitative, quantitative approach will be employed. The investigators will begin with a formative phase by conducting in-depth interviews with PWID (n = 40) living in the region to understand how the context of drug use and HIV risk changed as a result of the violence and will administer a social network survey (n = 200) to characterize the configuration of risk networks. Findings will yield the necessary information to culturally adapt the
Primary Outcome
assessed by the ratio of number of sex acts in exchange for drugs and the number of those acts without a condom.
Interventions
- BEHAVIORAL Community Events
- BEHAVIORAL Social Network HIV Testing
- BEHAVIORAL Peer Network Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 840 participants |
| Start Date | 2017-09-07 |
| Est. Completion | 2022-12-10 |
| Phase | NA |
What the finished NCT03293875 record still lists
NCT03293875 is an interventional study that assigns participants to a tested intervention. The registered 840 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (40% lower).
The record links to 0 conditions, and to 3 interventions - of which Community Events is the first listed.
NCT03293875 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03293875 about?
NCT03293875 is a clinical study titled "Adaptation and Implementation of Project Encuentro in the U.S.-Mexico Border". The proposed project is a research collaboration between the University of Texas at El Paso, The Alliance for Border Collaboratives in El Paso, Texas and Programa Companeros in Juarez City, Mexico to adapt, implement, and evaluate a multi-level community-based HIV prevention intervention (Project En...
What is the current status of trial NCT03293875?
This trial is currently completed. It is a NA study. The enrollment target is 840 participants. The study started on 2017-09-07. Estimated completion is 2022-12-10.
What interventions are being tested in trial NCT03293875?
The interventions under investigation include: Community Events (BEHAVIORAL), Social Network HIV Testing (BEHAVIORAL), Peer Network Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT03293875?
This trial is sponsored by City University of New York, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03293875's enrollment target sits among peer trials
840 133rd of 2000 higher than 1,867 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04831580 · 840 participants · NA
A Trial of Robotic Versus Open Hysterectomy Surgery in Cervix Cancer
- NCT04976881 · 840 participants · NA
Promoting Preconception Care and Diabetes Self-Management Among Reproductive-Aged Women With Diabetes
- NCT04985903 · 840 participants · NA
Baby Steps III: Testing a Clinician and Patient Intervention to Promote Smoking Cessation Among Pregnant Women
- NCT05384626 · 840 participants · Phase 1
A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI